| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2017-07-03 |
4 |
B |
$4.00 |
$741,568 |
I/I |
185,392 |
1,383,421 |
1.5 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
45,000 |
1,389,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-08 |
4 |
B |
$18.46 |
$923,000 |
I/I |
50,000 |
1,393,642 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2004-07-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
1,395,109 |
|
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-12-12 |
4 |
A |
$7.81 |
$185,250 |
D/D |
19,752 |
1,395,209 |
|
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-12 |
4 |
S |
$94.26 |
$7,787,384 |
D/D |
(82,616) |
1,407,742 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-09 |
4 |
B |
$18.54 |
$493,164 |
I/I |
26,600 |
1,420,242 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,434,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-10 |
4 |
B |
$18.81 |
$462,369 |
I/I |
24,581 |
1,444,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-13 |
4 |
B |
$18.98 |
$379,600 |
I/I |
20,000 |
1,464,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-14 |
4 |
B |
$19.19 |
$191,900 |
I/I |
10,000 |
1,474,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-15 |
4 |
B |
$20.80 |
$208,000 |
I/I |
10,000 |
1,484,823 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-09-12 |
4 |
S |
$93.32 |
$4,666,000 |
D/D |
(50,000) |
1,490,358 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-16 |
4 |
B |
$21.18 |
$211,800 |
I/I |
10,000 |
1,494,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-17 |
4 |
B |
$22.00 |
$121,000 |
I/I |
5,500 |
1,500,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-01 |
4 |
B |
$25.15 |
$377,250 |
I/I |
15,000 |
1,515,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-02 |
4 |
B |
$24.84 |
$372,600 |
I/I |
15,000 |
1,530,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-05 |
4 |
B |
$25.00 |
$2,500 |
I/I |
100 |
1,530,423 |
2.17 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-09-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
51,070 |
1,539,018 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-09-11 |
4 |
S |
$92.98 |
$4,649,000 |
D/D |
(50,000) |
1,540,358 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-19 |
4 |
S |
$0.21 |
$7,430 |
I/I |
(36,000) |
1,566,956 |
0 |
% |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-07-03 |
5 |
GD |
$0.00 |
$0 |
D/D |
270 |
1,590,088 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2011-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
63,000 |
1,590,358 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-08 |
4 |
S |
$0.24 |
$8,320 |
I/I |
(35,000) |
1,602,956 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-08 |
4 |
A |
$15.01 |
$1,208,305 |
I/I |
80,500 |
1,610,923 |
0 |
- |
|
634 Records found
|
|
Page 10 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
